Spire Healthcare Group PLC’s (SPI) “Add” Rating Reaffirmed at Numis Securities Ltd
Numis Securities Ltd restated their add rating on shares of Spire Healthcare Group PLC (LON:SPI) in a research report report published on Thursday morning. They currently have a GBX 350 ($4.52) price objective on the stock.
Several other analysts have also recently issued reports on SPI. Liberum Capital reaffirmed a buy rating and set a GBX 400 ($5.17) target price on shares of Spire Healthcare Group PLC in a research report on Friday, May 26th. Jefferies Group LLC increased their target price on Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the company a hold rating in a research report on Thursday, June 1st. Berenberg Bank increased their target price on Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the company a buy rating in a research report on Wednesday, June 21st. Finally, Credit Suisse Group reaffirmed an underperform rating on shares of Spire Healthcare Group PLC in a research report on Friday, July 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of GBX 347 ($4.48).
Shares of Spire Healthcare Group PLC (LON SPI) opened at 256.70 on Thursday. The company’s market capitalization is GBX 1.03 billion. Spire Healthcare Group PLC has a 12-month low of GBX 230.40 and a 12-month high of GBX 411.00. The firm has a 50-day moving average price of GBX 327.79 and a 200 day moving average price of GBX 332.90.
Spire Healthcare Group PLC (LON:SPI) last announced its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The business had revenue of £481 million for the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. On average, equities research analysts predict that Spire Healthcare Group PLC will post $18.48 earnings per share for the current year.
The business also recently announced a dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Thursday, November 16th will be given a dividend of GBX 1.30 ($0.02) per share. The ex-dividend date is Thursday, November 16th. This represents a yield of 0.5%.
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Stock Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related stocks with our FREE daily email newsletter.